^NBI

NASDAQ Biotechnology

Nasdaq GIDSUSDEQUITY DELAYED

7,285.19

▲ 96.66 (1.34%)

MARKET · —

Price

Open

7,222.53

Prev close

7,188.54

Day high

7,347.60

Day low

7,209.03

Volume

—

Market cap

—

P/E (TTM)

—

52W range

4,643.00 – 7,410.97

Trailing performance

Price return · vs SPY

Returnvs SPY

+7.14% +8.5%

+11.63% +7.9%

+23.45% +20.3%

+21.84% +10.8%

YTD

+27.65% +15.4%

+55.39% +35.4%

+80.06% +5.9%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

6,993.75

+4.17% from price

SMA 20

6,783.21

+7.40% from price

SMA 50

6,569.05

+10.90% from price

SMA 100

6,237.80

+16.79% from price

SMA 200

6,001.41

+21.39% from price

EMA 12

6,983.84

+4.32% from price

EMA 26

6,796.25

+7.19% from price

EMA 50

6,596.81

+10.44% from price

RSI (14)

69.3

Neutral

MACD (12,26,9)

187.58

Hist 51.96

ATR (14)

146.26

2.01% of price

Realised vol 30D

25.7%

Annualised

Bollinger upper

7,313.53

20, 2σ

Bollinger lower

6,252.89

20, 2σ

50 / 200 cross

Golden

6,569.05 vs 6,001.41

Trend bias

Above 200

+21.39%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.73

Less volatile than market

Correlation to SPY

0.44

Loosely linked

Realised vol 30D

25.7%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-8.5%

Peak to trough

Max drawdown 5Y

-38.3%

Peak to trough

ATR 14

146.26

2.01% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 7,285.19

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.